20172cites
Short communication: Non-malaria related acute fever, a preliminary study from Kinshasa the Democratic Republic of the CongoInternational journal of tropical medicine and public health, Mosquito-borne diseases and control
UniversitiesVivi Maketa
Active, last published 2026
In malaria research and control
Vivi
Maketa
“Research focused on Malaria Research and Control and adjacent fields.”
University of Kinshasa
Claim Your Profile11
H-index
504
Citations
Vivi has not officially claimed their profile. If you are Vivi, claim it free.
Claim Your Profile01 · About the work
What I study
ivi Maketa is a researcher working on Malaria Research and Control. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Vivi's work has been cited 504 times across 8 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
05 · Research focus
Topics
Malaria Research and Control×19Viral Infections and Outbreaks Research×19Mosquito-borne diseases and control×16Vaccine Coverage and Hesitancy×14Parasites and Host Interactions×13
06 · Where I am
Affiliations
CurrentlyUniversity of Kinshasa
Research themes (UN SDGs)
07 · Selected work
Recent publications
View all 69 works2019Open access
Latent tuberculosis infection in HIV-infected adults of Kinshasa, DR CongoResearch Square, Tuberculosis Research and Epidemiology
2021Open access11cites
Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the CongoBMJ Global Health, Viral Infections and Outbreaks Research
2021Open access
Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study (Preprint)2022Open access10cites
Comparison of intermittent screening (using ultra-sensitive malaria rapid diagnostic test) and treatment (using a newly registered antimalarial pyronaridine-artesunate—PYRAMAX®) to standard intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria in pregnant women living in endemic areas: ULTRAPYRAPREGTrials, Malaria Research and Control
Are you Vivi?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required